{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P01137",
      "entity_text" : "TGF-beta1",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0568" ],
      "Species" : [ "taxonomy:10116" ]
    }
  },
  "verbose_text" : "Treatment with EGCG, but not DEX, reduced mortality rates and lung index scores, improved histological changes in the lung, reduced collagen depositions, reduced MDA content, enhanced SOD activity, inhibited (myo) fibroblast proliferation, protected alveolar epithelial type II (AE2) cells, and regulated serum levels of TGF-beta1, IL-6, IL-10, and TNF-alpha.",
  "reading_complete" : "2020-08-03T16:06:00Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T16:04:37Z",
  "trigger" : "levels",
  "evidence" : [ "levels of TGF-beta1" ],
  "pmc_id" : "4072398",
  "score" : 0
}